Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Elliott

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2024
Iron biologyLucia Del Vecchio, Domenico Girelli, Francesca Vinchi, et al.
Toxicologic Pathology|May 16, 2013
Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocritDina A Andrews, Babette M Boren, James R Turk, et al.
Nature Biotechnology|March 4, 2003
Enhancement of therapeutic protein in vivo activities through glycoengineeringSteve Elliott, Tony Lorenzini, Sheilah Asher, et al.
Toxicologic Pathology|May 16, 2013
Cytokines associated with increased erythropoiesis in Sprague-Dawley rats administered a novel hyperglycosylated analog of recombinant human erythropoietinDina A Andrews, Hisham K Hamadeh, Yudong D He, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2024
Iron biologyLucia Del Vecchio, Domenico Girelli, Francesca Vinchi, et al.
Toxicologic Pathology|May 16, 2013
Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocritDina A Andrews, Babette M Boren, James R Turk, et al.
Nature Biotechnology|March 4, 2003
Enhancement of therapeutic protein in vivo activities through glycoengineeringSteve Elliott, Tony Lorenzini, Sheilah Asher, et al.
Toxicologic Pathology|May 16, 2013
Cytokines associated with increased erythropoiesis in Sprague-Dawley rats administered a novel hyperglycosylated analog of recombinant human erythropoietinDina A Andrews, Hisham K Hamadeh, Yudong D He, et al.
Pageof 4